Skip to main content

Table 3 Multivariate Cox proportional hazard model of overall survival in all patients. Note:

From: Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study

Variables

Overall Survival

Hazard Ratio (95% Confidence Interval)

P c

Race

White

Reference

 

Black

0.946 (0.781–1.146)

0.570

Other a

0.818 (0.622–1.077)

0.152

Marital status

Married

Reference

 

Not married b

1.456 (1.291–1.641)

< 0.001

Missing

1.015 (0.761–1.354)

0.921

Histology

Ductal

Reference

 

Other d

0.886 (0.778–1.009)

0.067

Grade

Well

Reference

 

Moderately

1.194 (0.963–1.479)

0.106

Poorly/undifferentiated

1.427 (1.142–1.783)

0.002

Missing

1.330 (1.046–1.693)

0.020

Tumor size

T1

Reference

 

T2

1.215 (1.057–1.395)

0.006

T3/4

1.813 (1.448–2.270)

< 0.001

Missing

0.608 (0.355–1.041)

0.070

Nodal status

N0

Reference

 

N1

1.197 (1.021–1.403)

0.027

N2/3

1.612 (1.317–1.973)

< 0.001

Missing

2.350 (1.387–3.981)

0.001

Estrogen Receptor

Positive

Reference

 

Negative

1.403 (0.927–2.123)

0.110

Missing

1.223 (0.714–2.094)

0.464

Progesterone Receptor

Positive

Reference

 

Negative

1.193 (0.937–1.520)

0.152

Missing

0.855 (0.507–1.441)

0.557

Surgery approach

Breast Conserving Surgery

Reference

 

Mastectomy

0.755 (0.583–0.979)

0.034

Missing

0.814 (0.618–1.072)

0.144

Radiation status

No

Reference

 

Yes

0857 (0.736–0.997)

0.046

Chemotherapy status

No

Reference

 

Yes

0.822 (0.682–0.991)

0.040

  1. a Other includes American Indian/Alaskan native and Asian/Pacific Islander and Unknown
  2. b Not married includes divorced, separated, single (never married), unmarried or domestic partner, and widowed
  3. cP value was adjusted by a multivariate Cox proportional hazard regression model and bold type indicates significance
  4. d Other represents all pathological types other than invasive ductal breast cancer, including invasive lobular carcinoma, medullary carcinoma, mucinous carcinoma, intraductal papilloma, papillary carcinoma, tubular carcinoma, and so on